modern oncology

Tecentriq SC is a newer injectable version of the immunotherapy drug Tecentriq that could significantly reduce cancer treatment administration time. Instead of long IV infusion sessions, eligible patients may receive treatment in approximately seven minutes. This breakthrough has generated global attention because it could improve convenience, reduce hospital burden, and help modernize cancer care for both patients and oncology clinics.